Doug Besch insider trades

Open-market stock purchases and sales by Doug Besch, Chief Product & Tech Officer at OptimizeRx Corp, from SEC Form 4 filings since Oct 3, 2022.

Recent trades

DateStockTradeValue
Dec 23, 2025OPRX OptimizeRx CorpSold (not open market)$52K
Dec 19, 2025OPRX OptimizeRx CorpSold (not open market)$7.8K
Dec 19, 2025OPRX OptimizeRx CorpBought (not open market)—
Oct 3, 2025OPRX OptimizeRx CorpSold (not open market)$18.4K
Oct 3, 2025OPRX OptimizeRx CorpBought (not open market)—

Companies traded

  • OPRX OptimizeRx Corp: other filings, last Dec 23, 2025

Get free alerts when Doug Besch files a new trade →